Keebeck Alpha, LP Merck & Co., Inc. Transaction History

Keebeck Alpha, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 01, 2023	BUY	$83.49 - $94.64 $56,355 - $63,882	675 Added 6.45%	11,133 $1.02 Million
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $56,355 - $63,882	675 Added 6.45%	11,133 $1.02 Million
Q1 2022 Feb 01, 2023	SELL	$73.51 - $82.4 $49,619 - $55,620	-675 Reduced 6.06%	10,458 $858,000
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $220,530 - $247,200	3,000 Added 40.23%	10,458 $858,000
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $179,688 - $225,082	2,486 Added 50.0%	7,458 $572,000
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $356,840 - $396,019	4,972 New	4,972 $407,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.